Pharm2Farm: Revolutionary Anti-viral Face Mask Kills 99.9% of Covid-19 Virus on Contact
New Pro-Larva mask incorporates unique British copper nanoparticle technology to create a virucidal barrier effective against Covid-19 and other viruses, including influenza
A new anti-viral mask which kills 99.9% of Covid-19 virus within five minutes of contact has been launched today offering an unparalleled level of protection against viruses not just for those around them but for the wearer too.
Aimed at all types of industry, from hospital and care homes, to schools, to the retail leisure industries, Pro-Larva differs from conventional masks because, as well as protecting those around the wearer, it protects the wearer themselves, using revolutionary copper nanoparticle technology developed here in the UK.
Update on commissioning of mask making machine
The Company announces that the mask making machine at its subsidiary, Pharm 2 Farm Ltd ( P2F ), in BioCity, Nottingham, is operational and ready to produce the 4-ply anti-viral mask created by P2F.
As previously announced the maximum production capacity of the machine was expected to be around 5 million masks per month, based on the machine being operated for 24 hours per day and 7 days per week. The current production rate is significantly below these levels and the commissioning process has identified a number of issues that need to be resolved over the coming weeks in order to improve the machine s productive capacity. The Company is in discussions regarding the appointment of an independent adviser to assist P2F with the development of the production facility, including building up the production team to operate a single shift and enabling a gradual increase from the current limited level of production to commence, and to un